Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00742781 · ClinicalTrials.gov registry record · Phase 1

Vitamin D Supplementation in Crohn's Patients

A Phase 1 study, sponsored by Penn State University.

Completed
Registry status
Phase 1
Development phase
21
Enrollment target

NCT00742781 is a Phase 1 study that has completed, run by Penn State University. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00742781, a Phase 1 study, has completed, sponsored by Penn State University.

COMPLETED
Registry status
Phase 1
Development phase
21 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effect of vitamin D supplementation in Crohn's disease patients. Patients will be evaluated for increases in circulating vitamin D levels and effects on health benefits including improved bone markers, Crohn's disease activity scores, and inflammatory markers.

Interventions

  • DIETARY_SUPPLEMENT Vitamin D

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2009-05
Est. Completion 2011-12
Phase Phase 1

Sponsor

Penn State University

219 total trials

What the Registry Record Tells You About NCT00742781

The ClinicalTrials.gov registry entry for NCT00742781 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Vitamin D is the first listed.

NCT00742781 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00742781 about?

NCT00742781 is a clinical study titled "Vitamin D Supplementation in Crohn's Patients". The purpose of this study is to determine the effect of vitamin D supplementation in Crohn's disease patients. Patients will be evaluated for increases in circulating vitamin D levels and effects on health benefits including improved bone markers, Crohn's disease activity scores, and inflammatory ma...

What is the current status of trial NCT00742781?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2009-05. Estimated completion is 2011-12.

What interventions are being tested in trial NCT00742781?

The interventions under investigation include: Vitamin D (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00742781?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.